Progressive Pulmonary Fibrosis
Progressive Pulmonary Fibrosis (PPF) is a lung disease characterized by the gradual scarring of lung tissue, which can lead to severe breathing difficulties and reduced oxygen supply to the body.
Progressive Pulmonary Fibrosis: FAPI-PET Imaging Study
We are exploring if a special imaging method can help identify the type of lung condition in patients with progressive pulmonary fibrosis. This may improve how we understand and treat their disease.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have an active cancer diagnosis?
- Have you ever been treated with antifibrotic drugs?
- Are you currently pregnant?
- Do you have a new diagnosis of pulmonary fibrosis or related lung issues?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
AlF-FAPI-74
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
St Antonius Hospital
Department of Nuclear Medicine
Nieuwegein, Netherlands
Sponsor: St Antonius Hospital
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.